Have a personal or library account? Click to login
Incidence and prevention of post-immunisation bleeding complications in people with haemophilia at a treatment centre in India Cover

Incidence and prevention of post-immunisation bleeding complications in people with haemophilia at a treatment centre in India

Open Access
|Jun 2025

References

  1. Sørensen B, Benson GM, Bladen M, et al. Management of muscle haematomas in patients with severe haemophilia in an evidence-poor world. Haemophilia 2012; 18(4): 598–606. doi:10.1111/j.1365-2516.2011.02720.x.
  2. Srivastava A, Santagostino E, Dougall A, et al. WFH Guidelines for the Management of Hemophilia, 3rd edition [published correction appears in Haemophilia 2021; 27(4): 699. doi: 10.1111/hae.14308]. Haemophilia. 2020;26 Suppl 6:1–158. doi:10.1111/hae.14046.
  3. Khair K. Management of haemophilia in children. Paediatrics and Child Health 2019; 29(8): 334–338. doi: 10.1016/j.paed.2019.05.002.
  4. Platokouki H, Fischer K, Gouw SC, et al. Vaccinations are not associated with inhibitor development in boys with severe haemophilia A. Haemophilia 2018; 24(2): 283–290. doi:10.1111/hae.13387.
  5. Santagostino E, Riva A, Cesaro S, et al. Consensus statements on vaccination in patients with haemophilia-Results from the Italian haemophilia and vaccinations (HEVA) project. Haemophilia 2019; 25(4): 656–667. doi:10.1111/hae.13756.
  6. Ministry of Health and Family Welfare, Government of India. National Family Health Survey (NFHS-5), 2019–21. India Report. March 2022. Available from https://dhsprogram.com/pubs/pdf/FR375/FR375.pdf.
  7. UNICEF. Immunization and Child Health. Available from https://www.unicef.org/india/what-we-do/immunization.
  8. Ministry of Health and Family Welfare, Government of India. Immunization Handbook for Medical Officers. Reprint 2017. Available from https://nhm.gov.in/New_Updates_2018/NHM_Components/Immunization/Guildelines_for_immunization/Immunization_Handbook_for_Medical_Officers%202017.pdf.
  9. Astermark J, Altisent C, Batorova A, et al. Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report. Haemophilia 2010; 16(5): 747–766. doi:10.1111/j.1365-2516.2010.02231.x.
  10. Orto C, Harrison T. Route of administration for immunizations in haemophiliacs. Haemophilia 1995; 1(3): 215. doi:10.1111/j.1365-2516.1995.tb00075.x.
  11. Azarpanah H, Farhadloo M, Vahidov R, Pilote L. Vaccine hesitancy: evidence from an adverse events following immunization database, and the role of cognitive biases. BMC Public Health 2021; 21(1): 1686. doi:10.1186/s12889-021-11745-1.
  12. Tasar S, Tasar MA, Alioglu B. Vaccination in children with inherited bleeding disorders: Does the use of plasma and factor affect the response to the vaccine: An institutional registry. Haemophilia 2022; 28(1): 80–85. doi:10.1111/hae.14461.
  13. Fessard C, Riche O, Cohen JH. Intramuscular versus subcutaneous injection for hepatitis B vaccine. Vaccine 1988; 6(6): 469. doi:10.1016/0264-410x(88)90093-x.
  14. Carpenter SL, Soucie JM, Presley RJ, et al. Hepatitis B vaccination is effective by subcutaneous route in children with bleeding disorders: a universal data collection database analysis. Haemophilia 2015; 21(1): e39–e43. doi:10.1111/hae.12569.
  15. Makris M, Conlon CP, Watson HG. Immunization of patients with bleeding disorders. Haemophilia 2003; 9(5): 541–546. doi: 10.1046/j.1365-2516.2003.00819.x.
  16. Hochart A, Falaise C, Huguenin Y, Meunier S. Intramuscular vaccination of haemophiliacs: Is it really a risk for bleeding? Haemophilia 2019; 25(5): e322–e323. doi:10.1111/hae.13808.
Language: English
Page range: 57 - 64
Published on: Jun 7, 2025
Published by: Haemnet Ltd
In partnership with: Paradigm Publishing Services
Publication frequency: 1 times per year

© 2025 Tenzin Zompa, Sandra Mary Abraham, Tenzin Tseten, Tenzin Palkyi, Alfiya Muhammed, MV Archana, Raghavendra Nayak, Sulochana Badagabettu, published by Haemnet Ltd
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.